Thomas O. Kohl, Phd Email & Phone Number

Oklahoma City, Ok, Us

Framingham, Massachusetts, Us

Cultivated new business avenues within the biopharmaceutical industry, focusing on non-clinical and early-stage clinical entities for a variety of initiatives, including CDMO selection, management, business consulting, and intellectual property litigation support.

Somerset, Nj, Us

Cultivated new business opportunities for GMP release and stability testing for Biologics, enhancing the company's market presence among both prominent pharmaceutical and dynamic biotech firms.

Princeton, New Jersey, Us

Cultivated and expanded client relationships, securing new business in Biologics GMP release and stability testing for clinical and commercial stages, particularly within large pharmaceutical and dynamic biotechnology sectors in the Mid-Atlantic region.There are many analytical challenges throughout the product lifecycle. Through our specialized CMC expertise, we deliver the highest quality data that you need to overcome them.BiologicsReaching development milestones faster and effectively managing your program from discovery to post-launch requires specialised expertise and end-to-end solutions. Here are some of the areas where we can help you:- Safety, Identity, Strength, Quality and Purity Assessment- Product Lifecycle Management- Project Management

Malvern, Pa, Us

Orchestrated the development and validation of bioanalytical methods for small and large molecule quantification, ensuring adherence to non-GLP and GLP standards and facilitating technical and contractual negotiations.Directing business development initiatives related to the development and validation of immunoassays for large molecules, biotherapeutics and biomarkers to support all stages of pharmaceutical development. Alliance Pharma continues to support development of monoclonal antibody-based drugs by providing ligand binding assay services including client-specific method transfer or development, optimization and validation as well as specimen analyses to meet the client’s needs. Similarly, Alliance Pharma offers a range of services in method development and validation by state-of-the-art liquid chromatography and mass spectrometry (LC-MS/MS) as well as sample analyses for small molecules. Methods for both small and large molecules are validated to meet MHRA, FDA and/or ICH guidelines. In addition, Alliance Pharma offers services specific to new drug discovery and lead optimization efforts and provides complete in vitro and in vivo absorption, distribution, metabolism, and excretion (ADME) services for new chemical entities (NCEs) to accelerate drug discovery efforts.

Budapest, No, Hu

Developed and implemented business development strategies for monoclonal and polyclonal antibody services, addressing critical reagent requirements across Europe and the U.S.ImmunoGenes' patented technology platform IMG-AbS™ is an FcRn technology using genetically modified animals that overexpress the neonatal Fc Receptor (FcRn). Because of FcRn's role in antigen presentation, the company's animals are able to mount a strong immune response against weakly immunogenic targets.

Coordinated with CDMOs for the manufacture of monoclonal antibodies, ensuring adherence to GMP standards and supporting diagnostic assay development and clinical analyses.

Limerick, Pennsylvania, Us

Fostered client relationships and expanded business within Biotech and Pharma sectors by effectively managing project negotiations and leveraging scientific expertise.

Limerick, Pennsylvania, Us

Led a team in developing hybridoma-derived monoclonal and polyclonal antibodies, as well as antibody-based tools, ensuring project specifications and deliverables aligned with client expectations.

Us

Louisville, Ky, Us

Cape Town, Western Cape, Za

Cape Town, Western Cape, Za